The Trump administration is likely to face legal woes after revealing this week a proposal that would require drugmakers to include drug prices in direct-to-consumer television advertisements.
According to a STAT report, pharmaceutical companies on Monday further pressured the government to back off the effort, citing violations to their First Amendment rights.
The Centers for Medicare and Medicaid Services’ proposal would require pharma companies in their TV ads to disclose the list price of drugs covered by Medicare and Medicaid, and would extend to therapies costing more than $35.
“We will not wait for an industry with so many conflicting and perverse incentives to fix itself,” Health and Human Services Secretary Alex Azar said during a National Academy of Medicine event.
To read the full report on STAT, click here. (Paid subscription required)